Sebastian AlexanderAMayerMD

PubMed

• Transplant Outcomes in Myelofibrosis: Impact of Donor Type (Cord Blood Grafts Supported by CD34+ selected Cells [Haplo-Cord] Versus Matched Donors).
  Nima Ghalehsari, Franco Castillo Tokumori, Zhengming Chen, Marie Liu, Sebastian A Mayer
  Transplantation and Cellular Therapy. 2024-11-01
• Haplo-cord transplant. Realizing the potential of umbilical cord blood grafts. - A review of techniques and analysis of outcomes.
  Koen van Besien, Hongtao Liu, Seunghee Margevicius, Pingfu Fu, Andrew Artz
  Leukemia & Lymphoma. 2024-10-01
• 4 citations
  XPO1 Enables Adaptive Regulation of mRNA Export Required for Genotoxic Stress Tolerance in Cancer Cells.
  Rossella Marullo, Sarah C Rutherford, Maria V Revuelta, Nahuel Zamponi, Biljana Culjkovic-Kraljacic
  Cancer Research. 2024-01-02

Journal Articles

• Comparison of Subcutaneous versus Intravenous Alemtuzumab for Graft-versus-Host Disease Prophylaxis with Fludarabine/Melphalan Based Conditioning in Matched Unrelated ...  
  Patel K, Parmar S, Shah S, Shore T, Gergis U, Mayer S, van Besien K, Biol Blood Marrow Transplant, 1/30/2015
• FAM treatment for new onset bronchiolitis obliterans syndrome after hematopoietic cell transplantation  
  Kirsten M. Williams, Guang-Shing Cheng, Iskra Pusic, Madan Jagasia, Linda Burns, Vincent T. Ho, Joseph Pidala, Jeanne Palmer, Laura Johnston, Sebastian Mayer, Jason W...., Biol Blood Marrow Transplant, 1/22/2015
• A randomized phase II crossover study of imatinib or rituximab for cutaneous sclerosis after hematopoietic cell transplantation  
  Arai S, Pidala J, Pusic I, Chai X, Jaglowski S, Khera N, Palmer J, Chen GL, Jagasia M, Mayer SA, Wood WA, Green M, Hyun TS, Inamoto Y, Storer BE, Miklos DB, Shulman HM..., Clin Cancer Res, 1/16/2015
• Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation  
  Mukta Arora, Corey S Cutler; Madan  Jagasia, Joseph Pidala; Xiaoyu Chai, Paul J Martin; Mary E Flowers; Yoshihiro Inamoto; George L Chen; William A Wood; Nandita Khera..., Biol Blood Marrow Transplant, 1/2/2015
• A strategy to reduce donor specific HLA antibodies prior to allogeneic stem cell transplantation  
  U Gergis, S Mayer, B Gordon, T Mark, R Pearse, T Shore and K Van Besien, Bone Marrow Transplant, 1/17/2014
• A phase I study of CPX-351 in combination with Busulfan and Fludarabine conditioning and allogeneic stem cell transplantation in adult patients with refractory acute l...  
  Gergis U, Roboz G, Shore T, Ritchie E, Mayer S, Wissa U, McKenna M, Christos P, Pearse R, Mark T, Scandura J, van Besien K, Feldman E, Biol Blood Marrow Transplant, 1/1/2013
• A Phase 1 Study of Bendamustine and Melphalan Conditioning for Autologous Stem Cell Transplantation in Multiple Myeloma  
  Mark TM, Reid W, Niesvizky R, Gergis U, Pearse R, Mayer S, Greenberg J, Coleman M, Van Besien K, Shore T, Biol Blood Marrow Transplant, 1/1/2013
• A phase I study of epigenetic priming with Decitabine prior to standard induction chemotherapy in patients with AML  
  Scandura JM, Roboz GJ, Moh M, Morawa EW, Brenet F, Bose JR, Villegas L, Gergis US, Mayer SA, Ippoliti CM, Curcio TJ, Ritchie EK, Feldman EJ, Blood, 1/11/2011
• Thrombotic microangiopathies: Differential diagnosis, pathophysiology and therapeutic strategies Review  
  S. Mayer, L. Aledort, Mount Sinai Journal of Medicine, 1/1/2005
• Mechanism of SMRT Corepressor Recruitment by the BCL-6 BTB Domain  
  K. Ahmad, A. Melnick, S. Lax, D. Bouchard, J. Liu, Chih-Li Kiang, S. Mayer, S. Takahashi, J. Licht, and G. Prive, Molecular Cell, 1/1/2003
• Influence of drugs on myocardial iodine-123 metaiodobenzylguanidine uptake in rabbit myocardium  
  S. Mayer, G. Karanikas, Margarida Rodrigues, H. Sinzinger, European Journal of Nuclear Medicine, 1/1/2000
• Join now to see all

Books/Book Chapters

• Hematopoietic Stem Cell Transplants. Concepts, controversies and future directions. Chapter 26. 
  Chapter: Second allogeneic stem cell transplantation 
  S. Mayer, K. van BesienEditors: Editor: H. Lazarus.CambridgeEdition 1st,
• Proc. Radionuclides for Myocardium 
  Chapter: Pharmacological and non-pharmacological factors influencing myocardial 123I-MIBG-uptake. In vitro studies on human and experimental rabbit tissue. 
  Page 49 - 60S. Mayer, G. Karanikas, Margarida Rodrigues, M. Mehrabi, H. SinzingerEditors: G. Limouris, H.J. Biersack, K. C. Kouvis, S.A. Frangos, S.K. Shukla.Mediterranean Publ., Athens1999
• Proc. Radioactive Isotopes in Clinical Medicine and Research XXIII 
  Chapter: Factors influencing myocardial uptake of MIBG in-vitro. 
  Page 541 - 544S. Mayer, G. Karanikas, Margarida Rodrigues, H. SinzingerEditors: H.Bergmann, H. Koehn, H. Sinzinger.Birkhaeuser, Basel1999

Lectures

• Hematopoietic Stem Cell Transplant in Novel Agent Era Is Associated with Improved Survival in Relapsed and Refractory Peripheral T-Cell Lymphoma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Does Presence of Persistent Molecular Mutations Matter in AML Patients Undergoing Allogeneic Stem Cell Transplant? 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• CCR5 delta32 Cord & Haploidentical Grafts: Allogeneic Stem Cell Transplant for HIV+ /AML Patient: A Case Report from the Impaact P1107 Observational StudyClinically Re... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018